SKIN vs MRVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

SKIN

41.8
AI Score
VS
MRVI Wins

MRVI

56.5
AI Score

Investment Advisor Scores

SKIN

42score
Recommendation
HOLD

MRVI

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SKIN MRVI Winner
Forward P/E 25.5102 370.3704 SKIN
PEG Ratio 0.9262 0 Tie
Revenue Growth -7.8% 8.5% MRVI
Earnings Growth 0.0% -32.7% SKIN
Tradestie Score 41.8/100 56.5/100 MRVI
Profit Margin -9.8% -37.1% SKIN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SKIN 1M: -10.9% · 3M: -16.5% MRVI 1M: +7.0% · 3M: +33.9%

Current Technical Phase

SKIN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $0.63

MRVI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.6% over 20 days), RSI 61

RSI (14): 61.1 · Price: $7.90

Fundamentals Snapshot

Metric SKIN MRVI
Market Cap — —
Forward P/E 3.3 -80.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.7% 0.4%
Operating Margin 0.0% -0.3%
EPS -0.23 -0.52
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MRVI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.